Autologous bone graft and periosteal patch for large and recurrent talar osteochondral defect: A prospective study

自体骨移植和骨膜补片治疗大面积及复发性距骨骨软骨缺损:一项前瞻性研究

阅读:1

Abstract

BACKGROUND: Osteochondral injuries of the talus (OLT) are common as a variety of mechanisms causes them. Asymptomatic presentation with an underlying damaged bone and the overlapping symptoms with a simple sprain make OLT a potentially career-ending injury. The best surgical intervention aims to alleviate pain and improve long-term outcomes as well. These outcomes can be measured by 3 major clinical measurements: Visual analogue Score (VAS), American Orthopedic Foot and Ankle Society (AOFAS), and Foot and Ankle Disability Index (FADI), in addition to achieving the lowest complication rate possible. In this prospective study, we aim to evaluate the functional outcome of the treatment of large and recurrent OLT by osteoperiosteal patch. METHODS: Thirty patients with large (>1.5 cm(2)) or recurrent OLTs were prospectively treated using an osteoperiosteal graft. The procedure involved medial malleolar osteotomy, curettage of the lesion, followed by autologous cancellous bone grafting from the distal tibia, and periosteal transfer to cover the defect. RESULTS: VAS pain scores significantly decreased from a preoperative mean of 7.07 to 0.43 at the last follow-up. FADI scores significantly increased from 53.77 preoperatively to 93.8 at the last follow-up, indicating improved functional abilities. AOFAS scores also significantly increased from 40.6 preoperatively to 95.13 at the last follow-up, reflecting improvements in overall clinical status. The complication rate was low, with a few cases of superficial infection, DVT, and pain at the screw site, but no major complications related to the donor site. CONCLUSION: The osteoperiosteal graft technique is a safe and effective method for treating large and recurrent OLTs. This single-stage procedure offers significant improvements in pain, functional abilities, and overall clinical status, with results that align with other similar studies, while also avoiding donor site complications and disease transmission risks.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。